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OBJECTIVES The goal of this study was to investigate the association between the atherosclerotic arterial
remodeling and the incidence of cardiac events after coronary interventions in patients with
stable angina.
BACKGROUND The local mode of de novo atherosclerotic remodeling is associated with plaque vulnerability
and clinical symptoms. It may, therefore, reflect plaque morphology influencing the
long-term outcome after coronary interventions.
METHODS Quantitative angiography and intravascular ultrasound were obtained in 244 patients with
stable angina before and after single-vessel revascularization. On the basis of the lesion and
the reference segment vessel size, patients were categorized into three groups (adaptive [AR],
constrictive [CR] and intermediate [IR] remodeling). The lesion was analyzed for lumen,
total vessel and plaque areas. Clinical follow-up was obtained at a mean period of 7.7 6 3.7
months.
RESULTS Patients with CR had a higher rate of in-hospital complications (10.9% vs. 2.9% and 2.7% in
group CR vs. AR and IR, p 5 0.035). In contrast, patients with AR had the highest rate of
major adverse cardiac events (MACE) (44.3% vs. 25.5% in IR and 28.1% in CR, p 5 0.024)
with a predominance of revascularization at follow-up. Both target lesion restenosis (p 5
0.036) and nontarget lesion de novo stenosis (p 5 0.007) occurred more frequently in this
group. Adaptive remodeling was a significant predictor of MACE in multivariate analysis.
CONCLUSIONS Adaptive remodeling is associated with a higher rate of MACE, target lesion restenosis and
nontarget de novo stenosis. This finding may be due to differential responses of the adaptively
remodeled vessel to revascularization and a generally accelerated course of systemic athero-
sclerosis. (J Am Coll Cardiol 2000;36:1860–9) © 2000 by the American College of
Cardiology
Arterial remodeling is the geometric alteration of the
arterial vessel wall in response to the progression of athero-
sclerosis; it can be observed in both de novo and restenotic
lesions. This phenomenon involves either a large arterial
lumen despite a substantial atherosclerotic plaque size,
(adaptive remodeling [AR]) (1), or a smaller arterial lumen
than expected from the plaque size alone (constrictive
remodeling [CR]) (2). Constrictive remodeling has also
been found to contribute predominantly to the development
of restenosis after coronary interventions (3,4). The patho-
mechanism of the bidirectional pattern of vascular remod-
eling is not yet completely understood, but it is considered
to be, at least in part, related to adventitial processes (5).
Some reports have already reported the importance of
preexisting arterial remodeling as concerns the immediate
success and short- and long-term clinical outcomes of
coronary revascularization. However, the possible impacts
of different remodeling modes on the development of target
lesion restenosis in connection with or without acute myo-
cardial infarction (AMI) and cardiac death are still subject
to investigation. On the basis of the nature of the different
remodeling modes, a better clinical outcome for AR and
worse follow-up results for CR could be expected. However,
it has been shown that the mode of remodeling did not
influence the magnitude of the acute lumen gain after
balloon angioplasty (6). Moreover, the AR in coronary
arteries presenting in an unselected group of patients with
either stable or unstable angina was associated with a
significantly higher incidence of target lesion revasculariza-
tion (7–9). Preexisting adaptive remodeling proved to be a
prognostic factor for the occurrence of major adverse cardiac
events (MACE) in patients with unstable coronary heart
disease (10). The reason for the paradoxical worse clinical
outcome of patients with preexisting AR is thought to be
the biologically active unstable plaque (11).
The differentiation between stable and unstable angina is
based merely on the clinical symptoms (12) and does not
necessarily characterize the pathomorphology of the coro-
nary lesion. However, we, as well as other researchers, have
shown that unstable clinical symptoms are associated with
the mode of de novo atherosclerotic arterial remodeling
(13,14). The aim of the present prospective clinical intra-
vascular ultrasound (IVUS) study, therefore, was to inves-
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tigate the influence of the local remodeling modes on the
short- and long-term clinical outcomes of patients present-
ing only with stable angina pectoris.
METHODS
Patients. The clinical, angiographic and IVUS data on 491
consecutively enrolled patients (IVUS guided coronary in-
tervention between September 1995 and March 1999) at
the Division of Cardiology, Department of Internal Medi-
cine II, University of Vienna, were prospectively selected
and analyzed. All patients had given written informed
consent to cardiac catheterization and IVUS in accordance
with the institutional guidelines. Inclusion criteria were
symptomatic coronary artery disease, single-vessel coronary
intervention in a nonostial de novo lesion, IVUS before and
after coronary revascularization, available qualitative and
quantitative IVUS assessments and clinical follow-up. Pa-
tients after heart transplantation (n 5 69) and patients with
unstable angina pectoris (n 5 95) were then excluded. The
results of the patients with unstable angina have previously
been published elsewhere (10,13,15). We then excluded 83
patients with missing baseline or follow-up clinical data.
The data on the remaining 244 patients presenting with
stable angina were included in the further analyses.
Angina pectoris was considered to be stable when it was
brought on by exertion, resolved under nitrate-therapy and
had not changed in its characteristics (frequency, severity,
duration, time of appearance and precipitating factors) for
the previous 60 days (16). All patients were requested to
undergo follow-up angiography after six months and were
clinically followed up for 12 months. If patients developed
recurrent angina, angiography was performed at the occur-
rence of symptoms.
Demographic data (age and gender) and coronary risk
factors (family history of coronary artery disease, smoking,
medication-dependent diabetes mellitus, medication-
dependent hypertension and medication-dependent hyper-
cholesterolemia) were obtained from the patient’s chart. A
positive family history was defined as the existence of a male
first-degree relative with documented coronary artery dis-
ease at ,55 years of age or a female first-degree relative with
documented coronary artery disease at ,65 years of age.
Patients who had been smoking within the last three years
were classified as smokers.
Coronary angiography, IVUS and coronary intervention.
Biplane coronary angiography was performed in a routine
manner, the Judkin’s technique being used. After the
intracoronary administration of 150 to 200 mg nitroglycer-
ine, baseline angiograms were recorded in at least two
projections on either cine film or CD-ROM. After the
completion of coronary angiography, the culprit lesions
were identified, and IVUS imaging of these lesions was
performed, the description of which has been previously
published (13). Stenoses ,50% were only revascularized if
the patient had symptoms showing evidence of lesion-
related ischemia.
Before each IVUS procedure, 100 to 200 mg nitroglyc-
erine was administered, intracoronary, to prevent vaso-
spasm, and an IVUS imaging catheter was advanced at least
1.0 cm distal to the stenosis. The catheters used in this study
were 2.6, 2.9 or 3.2F mechanical imaging catheters (Boston
Scientific Corp., Sunnyvale, California) and 3.0F electronic
imaging catheter (EndoSonics, Rancho Cordova, Califor-
nia). The catheter was then pulled back manually or
automatically at a constant velocity of 0.5 mm/s, and the
images were recorded on s-VHS videotapes for subsequent
off-line analysis. Immediately before the intervention, the
patients received 250 mg aspirin and 10,000 IU heparin
intravenously. During the procedure the activated clotting
time was measured and was maintained at .300 s by
repeated intravenous heparin application. The interven-
tional device (balloon, stent, and directional atherectomy)
was chosen according to the angiographic and ultrasono-
graphic appearance of the lesion. Optimizing interventions
and IVUS guidance were performed at the interventionist’s
discretion. After finalization IVUS was performed as de-
scribed above. After the intervention patients were treated
with aspirin (100 mg); in the case of stenting, they took
aspirin (100 mg) for at least one year, and they took
ticlopidine (500 mg) for 30 days.
Angiographic analysis. Angiograms were analyzed in two
different sessions by two experienced observers blinded to
the ultrasonographic results. Consensus was achieved be-
tween the two observers with regard to the qualitative
angiographic parameters. Qualitative analysis was per-
formed according to clinical standards (17). Special empha-
sis was placed on proximal lesions and stenoses with type C
morphology, which have previously been found to have a
worse outcome. Quantitative angiographic measurements
were performed with a computer-assisted quantitative cor-
onary arteriographic edge-detection algorithm (for cinean-
giograms: Cardiovascular Measurement System, Medis, the
Netherlands; for CD-ROM: ACOMPC, Siemens, Germa-
ny), and the mean values of the two observer’s measure-
ments were calculated. End-diastolic frames were chosen for
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assessment of the minimal lumen diameter and reference
diameter, lengths of stenoses and percent diameter stenoses.
In the projection with the least amount of foreshortening,
the lesion length (in millimeters) was measured from the
proximal to the distal shoulder of the stenosis (18).
IVUS analysis. Intravascular ultrasound images obtained
via mechanical catheters were analyzed in off-line mode by
two experienced observers with a computer-assisted IVUS
analysis system (TapeMeasure, Indec Systems Inc., Capi-
tola, California). Those images obtained by electronic cath-
eters were analyzed on the EndoSonics Oracle Imaging
System (EndoSonics, Rancho Cordova, California).
The qualitative features of the culprit lesion were inde-
pendently determined by the two observers; in cases of
disagreement the final decision was obtained in a consensus
reading. We have previously published the underlying
definitions for plaque composition (soft, fibrocalcific, calci-
fication) and plaque eccentricity elsewhere (13). The plaque
was suspicious for containing thrombus when it had a
scintillating or sparkling appearance, with a finer tissue
structure and brighter individual speckles than soft plaque,
which was not affected by a contrast injection through the
guiding catheter. Plaque rupture was defined as an abrupt,
focal, superficial break in the linear continuity of the plaque
Figure 1. Different patterns of vascular remodeling in intravascular ultrasound. (A) Shows an example of adaptive remodeling with the external elastic
membrane at the lesion site being larger than that in the proximal reference segment. (B) Exhibits the physiological tapering from the proximal to the distal
direction (“intermediate remodeling”).
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that extended in a radial direction only. When irregularities
within the surface of the diseased vessel wall were observed
without actual rupture, the surface was classified as ulcerated
(19). The site of the minimum lumen cross-sectional area,
that is, the lesion site, was identified by carefully scrolling
the tape forward and back and by orientation on anatomic
landmarks. At the lesion site and in adjacent proximal and
distal reference segments, quantitative measurements were
performed by two independent observers as described be-
low, and the average value of the two measurements was
then calculated. For each segment the lumen area (mm2)
and the total vessel area (mm2) were measured in diastolic
frames by manually tracing the leading edge of the intima
and the external elastic membrane (EEM), respectively. The
plaque area, defined as intima 1 media area, was calculated
from the difference between the lumen and the total vessel
areas (mm2). The plaque burden (%) on each cross-section
was calculated as (plaque area/total vessel area) 3 100. The
proximal and distal reference segments were defined as the
segments closest to the lesion site (with no major side-
branch originating between the lesion site and the reference
site) with a plaque burden of ,50%.
Definitions. Major adverse cardiac events were considered
to be death, nonfatal AMI and revascularization. Target
lesion restenosis was defined as a lesion with $50% diam-
eter stenosis at the originally treated lesion site at follow-up.
Nontarget de novo stenosis was considered to be a signifi-
cant stenosis (percent diameter stenosis $50%) at any lesion
in any coronary artery except at the target site, which was
not present at the first angiography.
Intervention complications were defined as complications
during the coronary intervention. An acute complication
was defined as a complication within 24 h after the
intervention. In-hospital complications occurred after the
intervention and before hospital discharge. Intervention,
acute and in-hospital complications were AMI, life-
threatening cardiac arrhythmias with a need for resuscita-
tion or pacemaker implantation, rest angina with electro-
cardiogram changes, repeat acute revascularization and
death from any cause.
Adaptive remodeling was assumed when the EEM cross-
sectional area at the lesion site was larger than the proximal
reference EEM cross-sectional area, whereas a lesion EEM
cross-sectional area smaller than that at the distal reference
site was defined as CR. Intermediate remodeling (IR) was
present when the EEM cross-sectional areas of the lesion
was smaller than that of the proximal and larger than that of
the distal reference segment (Fig. 1).
Statistics. All data are expressed as means 6 standard
deviation for continuous variables. Categoric variables are
presented as frequencies. Comparisons between groups were
made with analysis of variance (ANOVA) for differences in
means or with the chi-square test for categorical variables,
respectively. Differences were considered to be significant
when p , 0.05.
Additionally, uni- and multivariate analyses were per-
formed in order to determine the confounding variables
effecting the results and to define the significant predictors
of in-hospital complications, composite MACE, target
lesion restenosis and nontarget lesion de novo stenosis as
dependent variables. First, all clinical, angiographic and
IVUS parameters were tested in univariate analyses; then
the significant parameters were entered into the multivariate
analyses. Odds ratios (OR) with 95% confidence intervals
(CI) were calculated for all significant predictors in multi-
variate analyses.
The follow-up events (MACE, target lesion restenosis
and nontarget de novo stenosis)—free survival functions
Figure 1 (continued). (C) Depicts a constrictively remodeled lesion, with a
significantly smaller external elastic membrane at the lesion site than in the
distal reference segment.
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(Kaplan-Meier curve)—were estimated and supplemented
with the log-rank test.
Data on reproducibility in our IVUS laboratory have been
published elsewhere (13). In brief, measurements on single
arterial segments were performed by two observers, and
regression analysis was used to assess the interobserver
variability. The coefficient of correlation of the interobserver
variability was r 5 0.956 (p , 0.001). One-way ANOVA
with repeated measurements was used to determine the
intraobserver variability and the reproducibility of IVUS
measurements. The standard error of the estimate of the
ANOVA was used to derive the methodological error. The
coefficient of variation of the repeated measurements of the
lumen and EEM diameter was 3%, whereas that of the
lumen and EEM cross-sectional area was 1.7%. The meth-
odological error of the measurement of the lumen and EEM
diameter was 0.19 mm and for the lumen and EEM
cross-sectional areas was 0.38 mm2.
RESULTS
The clinical, angiographic and IVUS data on 244 patients
presenting stable angina, comprising 196 men and 48
women (average age 59.1 6 10.9 years) were analyzed.
Control angiography within the first 12 months was ob-
tained in 196 patients (80.3%). Seventy (28.7%) patients
exhibited AR (group AR), 110 (45.1%) were classified as IR
(group IR), and 64 patients (26.2%) presented with CR
(group CR).
Clinical data. Overall, a positive family history was present
in 16.0%, smoking in 52.1%, diabetes mellitus in 15.6%,
hypertension in 36.5% and hypercholesterolemia in 74.2%.
In 132 patients (54.1%) lesions were revascularized by
stenting; in 70 (28.7%) balloon dilatation was performed as
a stand-alone procedure, and in 42 patients (17.2%) other
procedures (atherectomy, laser) were applied. The distribu-
tion of the intervention types did not differ between the
groups nor did the demographic and clinical baseline data
(Table 1). Six patients (5.5%) required treatment with
glycoprotein IIb/IIIa antagonists after intervention.
Qualitative and quantitative coronary angiography re-
sults. The patients in group IR suffered from multivessel
disease significantly less frequently than the other patients
did, with an overall frequency of 52.0%. The distribution of
analyzed arteries was as follows: 125 left anterior descending
(51.2%), 24 circumflex (9.8%) and 95 right coronary
(39.0%). The lesion was located in a proximal vessel
segment in 60.7%, and 22.5% were type C lesions. The
mean length of the stenoses was 7.91 6 4.45 mm. Before
intervention the mean minimal lumen diameter was 1.44 6
0.62 mm, which increased to 2.70 6 0.59 mm after the
coronary intervention. The pre- and postinterventional
reference diameter was 3.02 6 0.75 and 3.38 6 0.67 mm,
while the percentage of diameter stenosis decreased from
54.4 6 19.3% to 19.7 6 9.1%. The differences between the
groups in arterial dimensions as measured by quantitative
coronary angiography were not significant (Table 2).
IVUS analysis. Soft plaque was found in 37.3% of all
lesions; 23.4% displayed thrombotic components, and
40.2% presented calcification. The plaque was concentric in
65.2% of the lesions. Spontaneous plaque dissection/rupture
and ulceration were found in 16.8% and 14.8%. The
qualitative IVUS data did not differ significantly between
the groups although there was a trend toward a higher
frequency of thrombotic plaque components in the patients
with AR (28.6% vs. 20.3% in CR and 18.2% in IR, p 5
0.074; Table 3). For all patients the minimal lumen, plaque
and vessel areas and plaque burdens were: 4.24 6 2.40,
11.17 6 4.97 and 15.45 6 5.47 mm2 and 70.7 6 14.2%
before the intervention and 8.06 6 2.87, 7.46 6 3.87 and
15.59 6 5.34 mm2 and 47.1 6 12.5% after the intervention.
Before the coronary intervention, the plaque and vessel
areas were significantly larger in the patients with AR than
they were in those without (p , 0.001 and p 5 0.001,
respectively), whereas the minimal lumen area and plaque
burden did not differ between the three groups. After the
coronary intervention, the residual plaque area was signifi-
cantly larger in group AR than it was in groups CR and IR
(p 5 0.044; Table 3).
Table 1. Demographic Data
Group AR Group IR Group CR p Value
Number of patients 70 (28.7%) 110 (45.1%) 64 (26.2%) —
Age 58.8 6 12.2 59.0 6 9.6 59.6 6 11.6 NS
Men 52 (74.3%) 89 (80.9%) 50 (78.1%) NS
Diabetes mellitus 9 (12.9%) 15 (13.6%) 13 (20.3%) NS
Hypercholesterolemia 55 (78.6%) 81 (73.6%) 45 (70.3%) NS
Hypertension 25 (35.7%) 44 (40.0%) 23 (35.9%) NS
Smoking 31 (44.3%) 51 (46.4%) 42 (65.6%) NS
Family history 11 (15.7%) 16 (14.6%) 12 (18.8%) NS
PTCA 21 (30.0%) 31 (28.2%) 18 (28.1%) NS
Stent 36 (51.4%) 63 (57.3%) 33 (51.6%) NS
Other intervention 13 (18.6%) 16 (14.6%) 13 (20.3%) NS
Follow-up (months) 6.81 6 3.65 8.00 6 3.53 8.08 6 3.95 NS
AR 5 adaptive remodeling; CR 5 constrictive remodeling; IR 5 intermediate remodeling; PTCA 5 percutaneous transluminal
coronary angioplasty.
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Short- and long-term outcomes. Neither the coronary
intervention complications nor the occurrence of acute
complications differed significantly between the three
groups, with overall rates of 2.9% and 2.1%, respectively.
However, there was a trend towards a higher rate of
postinterventional dissections for patients with CR (10.9%
vs. 1.4% in group AR and 7.3% in group IR; p 5 0.078).
These patients also had the highest rate of in-hospital
complications after the interventions (10.9% vs. 2.9% and
2.7% in group CR vs. groups AR and IR, p 5 0.035). The
distribution of in-hospital complications was as follows:
three urgent percutaneous transluminal coronary angioplas-
ties (PTCA), one death, one ventricular fibrillation with
successful resuscitation, two rest angina pectoris with elec-
trocardiogram changes in group CR, two non-Q wave
AMIs in group AR and two non-Q wave AMIs and one
death in group IR.
Clinical follow-up was performed in all patients at a
mean period of 7.7 6 3.7 months. Follow-up angiogra-
phy was performed in 196 patients (80.7%). Major
adverse cardiac events occurred in 31.6% (77 patients) of
all patients: 44.3% in group AR but in only 28.1% of the
CR patients and 25.5% of the group IR patients (p 5
0.024; Table 4A).
The predominant event was revascularization in any
lesion with an overall frequency of 28.3% (69 patients).
Repeated angioplasty was performed significantly more
frequently for patients with AR (28 PTCA and 2 coronary
artery bypass grafting [CABG], 42.9%) than for patients in
groups CR (13 PTCA and 2 CABG, 23.4%) and IR (21
PTCA and 3 CABG, 21.8%; p 5 0.006). During the
follow-up period seven patients (2.9%) died, and six patients
(2.5%) suffered a nonfatal AMI (Table 4A). Target lesion
restenosis occurred significantly more frequently in patients
Table 2. Coronary Angiography: Qualitative and Quantitative Results
Group AR Group IR Group CR p Value
Multivessel disease 39 (55.7%) 39 (35.5%) 33 (51.6%) 0.015
LAD 33 (47.1%) 64 (58.2%) 28 (43.8%) NS
LCx 7 (10.0) 7 (6.4%) 10 (15.6%) NS
RCA 30 (42.9%) 39 (35.5%) 26 (40.6%) NS
Proximal lesion 35 (50.0%) 66 (60.0%) 47 (73.4%) NS
Type C 12 (17.1%) 27 (24.6%) 16 (25.0%) NS
Before intervention
Lesion length (mm) 7.18 6 3.57 8.00 6 5.20 8.38 6 3.98 NS
MLD (mm) 1.35 6 0.59 1.42 6 0.58 1.53 6 0.69 NS
RD (mm) 2.98 6 0.71 2.98 6 0.69 3.13 6 0.88 NS
%DS (%) 57.5 6 18.8 53.2 6 20.2 53.7 6 15.3 NS
After intervention
MLD (mm) 2.63 6 0.62 2.65 6 0.55 2.82 6 0.63 NS
RD (mm) 3.42 6 0.71 3.33 6 0.61 3.39 6 0.73 NS
%DS (%) 22.2 6 12.8 19.1 6 10.1 18.1 6 8.9 NS
Dissection 1 (1.4%) 7 (6.4%) 8 (12.5%) 0.078
AR 5 adaptive remodeling; CR 5 constrictive remodeling; IR 5 intermediate remodeling; LAD 5 left anterior descending
coronary artery; LCx 5 left circumflex coronary artery; MLD 5 minimal lumen diameter; RCA 5 right coronary artery; RD 5
reference diameter; %DS 5 percent diameter stenosis.
Table 3. Intravascular Ultrasound: Qualitative and Quantitative Results
Group AR Group IR Group CR p Value
Soft 25 (35.7%) 45 (40.9%) 21 (32.8%) NS
Concentric 43 (61.4%) 72 (65.5%) 44 (68.8%) NS
Thrombus 20 (28.6%) 20 (18.2%) 13 (20.3%) 0.074
Calcification 29 (41.4%) 44 (40.0%) 25 (39.1%) NS
Rupture/dissection 10 (14.3%) 20 (18.2%) 11 (17.2%) NS
Ulceration 13 (18.6%) 12 (10.9%) 11 (17.2%) NS
Before intervention
Lumen CSA (mm2) 4.49 6 2.47 4.17 6 2.54 4.08 6 2.45 NS
EEM CSA (mm2) 17.09 6 5.72 15.40 6 5.26 13.66 6 5.05 0.001
Plaque CSA (mm2) 12.71 6 5.46 10.72 6 4.70 9.42 6 4.33 , 0.001
Plaque burden (%) 71.7 6 12.3 71.9 6 13.6 67.3 6 16.9 NS
After intervention
Lumen CSA (mm2) 8.55 6 3.24 7.37 6 2.54 8.12 6 2.99 NS
EEM CSA (mm2) 16.90 6 5.83 16.85 6 5.31 15.79 6 4.88 NS
Plaque CSA (mm2) 8.36 6 3.95 7.12 6 3.92 6.35 6 3.70 0.044
Plaque burden (%) 47.4 6 11.7 42.3 6 11.7 42.3 6 10.8 NS
AR 5 adaptive remodeling; CR 5 constrictive remodeling; CSA 5 cross-sectional area; EEM 5 external elastic membrane;
IR 5 intermediate remodeling.
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with AR (p 5 0.036) and so did nontarget lesion de novo
stenosis (p 5 0.007; Table 4B).
Predictors for in-hospital complications, MACE, target
lesion restenosis and nontarget lesion de novo stenosis.
The in-hospital complications correlated only with the
presence of preexisting CR in the univariate analysis (p 5
0.042).
Major adverse cardiac events were significantly associated
with AR (p 5 0.018) and male gender (p 5 0.045) in the
univariate analysis. Multivariate analysis revealed only AR
as a significant predictor (p 5 0.036) for the occurrence of
MACE with an OR of 1.882 and a 95% CI of 1.864 to
2.530.
Target lesion restenosis showed a significant positive
correlation with AR (p 5 0.017), preintervention percent
diameter stenosis (p 5 0.049), plaque area (p 5 0.042),
EEM area (p 5 0.033) and postinterventional plaque area
(p 5 0.044). Multivariate analysis revealed AR (p 5 0.044,
OR: 1.239 with 95% CI of 1.156 to 1.511) as a significant
predictor for target lesion restenosis.
For nontarget lesion de novo stenosis univariate analysis
revealed a relation with AR (p 5 0.023), pre- and postin-
terventional EEM area (p 5 0.006 and p 5 0.003, respec-
tively) and multivessel disease (p 5 0.007) as significant
parameters. Multivariate analysis showed AR (p 5 0.047,
OR: 3.022, 95% CI: 2.944 to 4.226) as significant and
multivessel disease as borderline significant (p 5 0.067)
predictors for nontarget lesion de novo stenosis.
Event-free survival. The survival curves exhibited a signif-
icantly worse clinical outcome in the patients with AR with
regard to the composite MACE (Fig. 2A), target lesion
restenosis (Fig. 2B) and nontarget lesion de novo stenosis
(Fig. 2C). However, when the observation period was
restricted to the first six months, the event-free survival
function revealed only a trend towards a worse outcome in
patients with AR, without reaching the level of significance.
DISCUSSION
This study demonstrates the different clinical and angio-
graphic outcomes of preexisting AR, CR and IR for patients
with stable angina pectoris. As expected, these patients
present predominantly with nonadaptive remodeling (IR
and CR) (14). Constrictive remodeling is associated with a
higher rate of in-hospital complications after coronary
interventions, which do not transform into a worse late
clinical outcome. Adaptive remodeling is predictive of a
higher rate of composite MACE and both target lesion
restenosis and nontarget de novo stenosis. On the basis of
the significantly higher frequency of multivessel disease and
follow-up nontarget de novo stenosis, we may assume a
more progressive systemic atherosclerosis for patients pre-
senting with coronary artery AR.
CR and in-hospital complications. The coronary lesions
exhibiting CR features presented the smallest plaque area,
obviously as a consequence of the decreased vessel area,
while the lumen area was similar in all groups. The degree
of lumen narrowing in CR lesions is, therefore, primarily
independent of the size of plaque area and is merely the
result of a geometric compromise. The high proportion of
in-hospital complications in these patients leads to the
speculation of an only modest short-term interventional
success in terms of vessel stretch, plaque compression and
debulking, as suggested by the higher frequency of postin-
terventional dissections in this group.
AR and MACE. The results of our study indicate that AR
is associated with a higher frequency of MACE in patients
with stable angina. The plaque and vessel areas in the AR
group were significantly higher before the interventions,
which corresponds well to the first description of vascular
remodeling (1). We have previously shown that a higher
incidence of thrombus, as detected by IVUS, was associated
with AR in patients with unstable angina (13). In this study
we observed a similar trend, and we may suppose that the
presence of thrombotic components in clinically stable
patients might have an additional, although not sole, effect
on the development of adaptive vessel remodeling and on
the proliferative potential of the vessel wall. Generally, AR
seems to be associated with a worse outcome of coronary
interventions because patients with unstable angina, with
their known higher risk of MACE, had a higher occurrence
of AR than patients with stable angina (36.7% vs. 28.7%) at
the expense of IR (40.8% vs. 45.1%), but they had a
Table 4. Follow-up Data
(A) MACE
AR IR CR p Value
Death 1 (1.4%) 4 (3.6%) 2 (3.1%) NS
AMI 1 (1.4%) 3 (2.7%) 2 (3.1%) NS
Revascularization 30 (42.9%) 24 (21.8%) 15 (23.4%) 0.006
Composite MACE 31 (44.3%) 28 (25.5%) 18 (28.1%) 0.024
(B) Target Lesion Restenosis and Nontarget de novo Stenosis
AR IR CR p Value
TL restenosis 27 (38.6%) 24 (21.8%) 15 (23.4%) 0.036
Non-TL stenosis 21 (30.0%) 15 (13.6%) 11 (17.2%) 0.007
AMI 5 acute myocardial infarction; AR 5 adaptive remodeling; CR 5 constrictive remodeling; IR 5 intermediate remodeling;
MACE 5 major adverse cardiac event; TL 5 target lesion.
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comparable distribution of CR (26.2% vs. 23.3% [10]).
Considering the higher biological activity of AR lesions
(11), we may, thus, speculate on an enhanced development
of a hemodynamically significant lumen encroachment,
especially in large plaque areas, as expected in lesions
featuring AR. Moreover, we found a strikingly higher
incidence of eccentric (63%), soft (58%), thrombotic (78%),
ruptured (43%) plaques and smaller lumen cross-sectional
area for patients with unstable angina (10). It, therefore,
seems that there are morphological differences between the
lesions in stable and unstable angina. However, the term
“unstable angina” is characterized solely by clinical features
and does not necessarily correlate fully with the histological
features of plaque stability or instability.
Nontarget lesion de novo stenosis. Overall, we found a
high rate of de novo nontarget lesions in all patients within
one year of follow-up (20.3%). This may be related to the
distribution of risk factors, especially the high prevalence of
hypercholesterolemia (74.2%) and smoking history (52.1%).
Furthermore, the Kaplan-Meier event-free survival curves
of the three groups are comparable within the first six
months and are also comparable with other published data.
The mean follow-up period in our study was 7.7 6 3.7
months; however, we followed our patients for up to one
year. Since almost 50% presented multivessel disease, we
think that the occurrence of significant de novo lesions in
20% is not surprising. Interestingly, patients featuring AR
in the target lesion were more likely to develop nontarget
lesion de novo stenosis, despite similar risk profiles. Thus,
AR may not only be a peculiarity of the culprit lesion but
may represent a generally higher severity of atherosclerosis.
This hypothesis appears to be supported by the increased
frequency of multivessel disease in the AR group. Consid-
ering that the clinical characteristics and qualitative mor-
phologic data on lesions were similar in all three remodeling
groups, it seems that additional factors may exist that lead to
an overall progression of coronary artery disease for patients
presenting with AR in a coronary lesion. Since the degree of
vessel enlargement is often individually determined (20) and
associated with pathohistological markers for inflammation
and plaque vulnerability (11), the observation of AR might
reflect some state of vascular inflammation throughout the
coronary tract of such patients. These individually deter-
mined inflammatory processes may not only accelerate the
progression of atherosclerosis but may also induce plaque
rupture.
The survival curve revealed a significantly worse clinical
outcome for patients with AR during the one-year
follow-up period, while during the first six months there
was only a nonsignificant trend toward a higher incidence of
MACE and restenosis in these patients. Since we have
previously reported that AR is a significant predictor of
MACE during the first six months in patients with unstable
angina (10), it seems that the atherosclerotic progression in
patients with stable angina is slower as compared with that
in unstable clinical conditions.
Comparison with previous studies. Our results are par-
tially concordant with the recently published reports on
preinterventional AR as a predictor of target lesion revas-
cularization (7,9). However, there are important differences
in study design between our study and those reports, which
exclude a direct comparison. First, in the studies by Dangas
et al. (7) and Ahmed et al. (9), CR and IR were taken as one
group of lesions featuring “intermediate/negative remodel-
ing.” Second, the patients were included regardless of their
anginal status, and, thus, a high rate of unstable patients in
these two studies may have biased the results. Moreover, the
Figure 2. Kaplan-Meier survival curves with log-rank test for (A) com-
posite MACE, (B) target lesion restenosis and (C) nontarget de novo
stenosis. The curves reveal a significantly worse outcome for patients with
AR during the observation period of one year. Solid diamond 5 group AR;
solid circle 5 group CR; solid square 5 group IR. AR 5 adaptive
remodeling; CR 5 constrictive remodeling; IR 5 intermediate remodel-
ing; MACE 5 major adverse cardiac event.
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postinterventional plaque burden reported for all of the
patient groups of Dangas et al. (7) was surprisingly high
(64.1 6 10.53% and 66.6 6 10.99%), and this might also
strongly influence the follow-up results (21). However, in
that study nonstent interventions were assessed, and the
predictive role of AR in the target lesion revascularization
after stent implantation was evaluated separately (9). It is
well known that the mechanisms of restenosis differ after
specific interventions (22). Whereas the major pathomecha-
nism of in-stent restenosis is neointimal hyperplasia (23),
CR is primarily responsible for restenosis after balloon
angioplasty (24) and directional coronary atherectomy
(4,25). In our cohort more than one-half of the patients
were treated with stents. Interestingly, there is no general
accordance on a standardized therapy for the variations in
remodeling in the present clinical practice. Although the
distribution of revascularization techniques was similar in all
three groups, further studies to assess the effects of specific
interventional techniques on different remodeling modes in
separate patient groups (stable or unstable angina) are
needed.
Study limitations. Our study is based exclusively on ob-
servations in nonostial de novo stenoses, so the results may
not be applicable to restenotic and ostial lesions.
Furthermore, there were different types of interventions
performed in the included patients (mainly stenting). It is
conceivable that the predominant mechanism of a single
revascularization technique (debulking, plaque compression,
etc.) may be of different value in the various modes of
remodeling. However, the percentage of intervention tech-
niques did not differ significantly between the three groups.
For the determination of vascular remodeling, only a
single IVUS image in the culprit lesion was assessed
(“snapshot view”). The lesion may feature various geometric
differences along its length, so that the chosen frame may
not be characteristic of certain biological properties of the
entire stenosis. However, in view of the international
practice of defining vascular remodeling by comparison of
single segments (4,7,21,26), and in consequence of the
standardized methods of image selection within our IVUS
laboratory, our study presents a uniform and reproducible
data set with regard to quantitative description.
Soft plaque and slowly flowing blood with a speckled
echo might lead to thrombus misinterpretation. Although
several IVUS studies have reported data on thrombotic
plaque, the identification of thrombus is still one of the less
specific and sensitive aspects of IVUS imaging.
The observations on vessel geometry may be distorted by
either a vasospasm caused by the catheter, mimicking CR or
vasodilation as a response to nitroglycerine, mimicking AR.
Since all patients received the same antianginal therapy
before and during the procedure, the differences between
individual patients are reduced to a minimum. However, if
a vasospasm did occur during the IVUS procedure, the
catheter was removed immediately, and the procedure was
repeated after an intracoronary injection of nitroglycerine.
The final recording was then used for quantitative analysis.
Conclusions. Our study has shown that AR is associated
with an increased frequency of composite MACE, with a
predominance of revascularization and both target lesion
restenosis and nontarget de novo stenosis in patients with
stable angina. Whereas the high rate of in-hospital compli-
cations in patients featuring CR may be related to the vessel
injury caused by the intervention, the enhanced develop-
ment of restenoses and de novo stenoses in patients with AR
may be due to a generally accelerated course of systemic
atherosclerosis.
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